HERON THERAPEUTICS, INC. /DE/ Debt Securities, Available-for-sale, Realized Gain (Loss)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-06-30 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-03-31 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $5.00K, a 400.00% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was $1.00K.
- HERON THERAPEUTICS, INC. /DE/ debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2025-11-04 | $5.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $5.00K derived: sum of 3 quarters · filed 2026-08-10 | $5.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $5.00K derived: sum of 2 quarters · filed 2026-05-11 | $5.00K derived: sum of 3 quarters · filed 2026-05-11 | $5.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.00K derived: sum of 2 quarters · filed 2026-02-26 | $5.00K derived: sum of 3 quarters · filed 2026-02-26 | $5.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $1.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $1.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $1.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00K 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $1.00K 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $1.00K 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $1.00K 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2024-08-06 | $1.00K 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | $0.00 derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | $0.00 derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $0.00 derived: sum of 3 quarters · filed 2022-05-09 | $0.00 derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $8.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $8.00K 10-Q · filed 2020-11-05 | $8.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-05 | $8.00K 10-Q · filed 2020-08-05 | $8.00K derived: sum of 3 quarters · filed 2021-02-24 | $8.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $8.00K 10-Q · filed 2020-05-06 | $8.00K derived: sum of 2 quarters · filed 2021-02-24 | $8.00K derived: sum of 3 quarters · filed 2021-02-24 | $8.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $0.00 derived: sum of 3 quarters · filed 2021-02-24 | $0.00 10-K · filed 2021-02-24 | $77.00K 10-K · filed 2019-02-22 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | $7.00K 10-K · filed 2019-02-22 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||||||
| 2016-12-31 | $23.00K 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |